Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Pavmed Inc (NQ: PAVM ) 0.9000 +0.0500 (+5.88%) Streaming Delayed Price Updated: 10:57 AM EDT, Jul 12, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Pavmed Inc < Previous 1 2 3 Next > PAVmed Subsidiary Lucid Diagnostics Announces Launch of VA EsoGuard® Study March 24, 2022 From Lucid Diagnostics Inc. Via Business Wire PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers March 23, 2022 From Lucid Diagnostics Inc. Via Business Wire PAVmed Announces Successful First-in-Human Implantations of its PortIO™ Intraosseous Infusion System March 17, 2022 From PAVmed Inc. Via Business Wire PAVmed Appoints Shaun O’Neil as Chief Operating Officer February 24, 2022 From PAVmed Inc. Via Business Wire Evernorth Executive and Healthcare Services Industry Leader Joan Harvey Named to PAVmed Board of Directors February 15, 2022 From PAVmed Inc. Via Business Wire Lucid Diagnostics to Participate in a Fireside Chat at the BTIG MedTech Digital Health, Life Science, and Diagnostics Tools Conference February 10, 2022 From Lucid Diagnostics Inc. Via Business Wire PAVmed and Lucid Diagnostics Welcome New Full-Time Investor Relations Team January 12, 2022 From PAVmed Inc. and Lucid Diagnostics Inc. Via Business Wire Lucid Diagnostics to Participate in a Fireside Chat at the 24th Annual Needham Virtual Growth Conference January 06, 2022 From Lucid Diagnostics Inc. Via Business Wire PAVmed Subsidiary Lucid Diagnostics Launches EsoGuard Telemedicine Program in Partnership with UpScriptHealth December 01, 2021 From Lucid Diagnostics Inc. Via Business Wire Lucid Diagnostics to Present at Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum November 17, 2021 From Lucid Diagnostics Inc. PAVmed Inc. Via Business Wire PAVmed and Lucid Provide Business Update and Preliminary Third Quarter 2021 Financial Results November 16, 2021 From PAVmed Inc. and Lucid Diagnostics Inc. Via Business Wire PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers November 11, 2021 From Lucid Diagnostics Inc. Via Business Wire PAVmed and Lucid to Hold Joint Business Update Conference Call on November 16, 2021 November 03, 2021 From PAVmed Inc. and Lucid Diagnostics Inc. Via Business Wire Veris Health Showcased in PAVmed Digital Health Virtual Investor Event October 29, 2021 From PAVmed Inc. Via Business Wire Lucid Diagnostics’ EsoGuard Esophageal DNA Test Wins “Diagnostics Innovation of the Year” Award October 28, 2021 From Lucid Diagnostics Inc. Via Business Wire PAVmed Digital Health Subsidiary Veris Health Appoints Sunny Webb as Chief Technology Officer October 25, 2021 From PAVmed Inc. Via Business Wire ADDING MULTIMEDIA Lucid Diagnostics Appoints Suman Verma MD, PhD as Chief Scientific Officer October 21, 2021 From Lucid Diagnostics Inc. Via Business Wire Lucid Diagnostics Appoints Suman Verma MD, PhD as Chief Scientific Officer October 21, 2021 From Lucid Diagnostics Inc. Via Business Wire Lucid Diagnostics Announces Closing of Nasdaq Initial Public Offering October 18, 2021 From Lucid Diagnostics Inc. Via Business Wire Lucid Diagnostics Announces Pricing of Initial Public Offering October 13, 2021 From PAVmed Inc. Via Business Wire PAVmed Acquires EsophaCap Manufacturer CapNostics LLC October 07, 2021 From PAVmed Inc. Via Business Wire PAVmed to Host Digital Health Virtual Investor Event September 30, 2021 From PAVmed Inc. Via Business Wire PAVmed Subsidiary, Lucid Diagnostics, Files Registration Statement for Proposed Initial Public Offering September 23, 2021 From PAVmed, Inc. Via Business Wire PAVmed Subsidiary Veris Health Joins Microsoft for Startups Global Program and Engages Loka as Software Development Partner September 21, 2021 From PAVmed Inc. Via Business Wire PAVmed to Participate in September Investor and MedTech Conferences September 07, 2021 From PAVmed Inc. Via Business Wire PAVmed Provides Business Update and Preliminary Second Quarter 2021 Financial Results August 12, 2021 From PAVmed Inc. Via Business Wire PAVmed Subsidiary Lucid Diagnostics Launches First Lucid Test Centers August 10, 2021 From PAVmed Inc. Via Business Wire PAVmed to Present at the 41st Annual Canaccord Genuity Growth Conference August 05, 2021 From PAVmed Inc. Via Business Wire Global Industry Executive Aster Angagaw Joins PAVmed Subsidiary Lucid Diagnostics’ Board of Directors August 03, 2021 From PAVmed Inc. Via Business Wire CORRECTING and REPLACING PAVmed to Hold Business Update Conference Call on August 12, 2021 August 02, 2021 From PAVmed Inc. Via Business Wire < Previous 1 2 3 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.